Cargando…
DNA‐Mediated Assembly of Multispecific Antibodies for T Cell Engaging and Tumor Killing
Targeting T‐cells against cancer cells is a direct means of treating cancer, and has already shown great responses in clinical treatment of B‐cell malignancies. A simple way to redirect T‐cells to cancer cells is by using multispecific antibody (MsAb) that contains different arms for specifically “g...
Autores principales: | Pan, Liqiang, Cao, Chan, Run, Changqing, Zhou, Liujuan, Chou, James J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6974939/ https://www.ncbi.nlm.nih.gov/pubmed/31993277 http://dx.doi.org/10.1002/advs.201900973 |
Ejemplares similares
-
Multispecific Antibodies: DNA‐Mediated Assembly of Multispecific Antibodies for T Cell Engaging and Tumor Killing (Adv. Sci. 2/2020)
por: Pan, Liqiang, et al.
Publicado: (2020) -
Programmable multispecific DNA-origami-based T-cell engagers
por: Wagenbauer, Klaus F., et al.
Publicado: (2023) -
Redirected optimized cell killing (ROCK®): A highly versatile multispecific fit-for-purpose antibody platform for engaging innate immunity
por: Ellwanger, Kristina, et al.
Publicado: (2019) -
Human monoclonal antibodies and monoclonal antibody multispecificity.
por: Campbell, A. M., et al.
Publicado: (1987) -
Toward Drug-Like Multispecific Antibodies by Design
por: Sawant, Manali S., et al.
Publicado: (2020)